Your browser doesn't support javascript.
loading
Therapeutic efficacies of artemether-lumefantrine and dihydroartemisinin-piperaquine for the treatment of uncomplicated Plasmodium falciparum and chloroquine and dihydroartemisinin-piperaquine for uncomplicated Plasmodium vivax infection in Ethiopia.
Assefa, Ashenafi; Mohammed, Hussein; Anand, Anjoli; Abera, Adugna; Sime, Heven; Minta, Anna A; Tadesse, Mekonnen; Tadesse, Yehualashet; Girma, Samuel; Bekele, Worku; Etana, Kebede; Alemayehu, Bereket Hailegiorgis; Teka, Hiwot; Dilu, Dereje; Haile, Mebrahtom; Solomon, Hiwot; Moriarty, Leah F; Zhou, Zhiyong; Svigel, Samaly Souza; Ezema, Bryan; Tasew, Geremew; Woyessa, Adugna; Hwang, Jimee; Murphy, Matthew.
Affiliation
  • Assefa A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia. ashyaega@yahoo.com.
  • Mohammed H; Institute for Global Health and Infectious Diseases, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. ashyaega@yahoo.com.
  • Anand A; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Abera A; Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Sime H; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Minta AA; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Tadesse M; Ethiopian Public Health Institute, Addis Ababa, Ethiopia.
  • Tadesse Y; Epidemic Intelligence Service, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Girma S; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Bekele W; ICAP at Columbia University, Addis Ababa, Ethiopia.
  • Etana K; ICAP at Columbia University, Addis Ababa, Ethiopia.
  • Alemayehu BH; ICAP at Columbia University, Addis Ababa, Ethiopia.
  • Teka H; U.S. President's Malaria Initiative, USA Agency for International Development, Addis Ababa, Ethiopia.
  • Dilu D; World Health Organization, Addis Ababa, Ethiopia.
  • Haile M; Ethiopian Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Solomon H; ICAP at Columbia University, Addis Ababa, Ethiopia.
  • Moriarty LF; U.S. President's Malaria Initiative, USA Agency for International Development, Addis Ababa, Ethiopia.
  • Zhou Z; Ethiopian Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Svigel SS; Ethiopian Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Ezema B; Ethiopian Federal Ministry of Health, Addis Ababa, Ethiopia.
  • Tasew G; U.S. President's Malaria Initiative, Malaria Branch, US Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Woyessa A; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Hwang J; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
  • Murphy M; Malaria Branch, U.S. Centers for Disease Control and Prevention, Atlanta, GA, USA.
Malar J ; 21(1): 359, 2022 Dec 01.
Article in En | MEDLINE | ID: mdl-36451216

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria, Vivax / Malaria, Falciparum / Artemisinins / Antimalarials Type of study: Clinical_trials / Guideline / Screening_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Malar J Journal subject: MEDICINA TROPICAL Year: 2022 Document type: Article Affiliation country: Etiopia

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria, Vivax / Malaria, Falciparum / Artemisinins / Antimalarials Type of study: Clinical_trials / Guideline / Screening_studies Limits: Humans Country/Region as subject: Africa Language: En Journal: Malar J Journal subject: MEDICINA TROPICAL Year: 2022 Document type: Article Affiliation country: Etiopia